Abstract. The effects and mechanism of juglone alone or combined with 5-fluorouracil on colon cancer CT-26 cells were examined in vivo. Starting at 5 weeks of age, male Balb/c mice were transplanted the CT-26 cells and treated with juglone alone or combined with 5-fluorouracil. Observed the morphologic characteristics of tumor tissue by HE staining after treatment of 9 days. We detected the content of IL-2, VEGF and IFN-γ in serum and the protein expression of ki-67, E-cad and Bcl-2 in tumor tissue. The inhibition rate of animals given low-dose or high-dose juglone alone and combined with 5-fluorouracil is 31.73%, 40.38%, 56.73% and 75.01% respectively. Animals given juglone alone or combined with 5-fluorouracil could increase the content of IL-2 and IFN-γ in serum and the expression of E-cad and decrease the content of VEGF in serum and the expression of ki-67 and Bcl-2 significantly compared with those injected 2% ethanol NS (P<0.05 in each). The present data suggest that the juglone could reduce the risk of CT-26 cells metastasis and proliferation and enhance the function of the immune system. The possible anti-tumor mechanism of juglone is down-regulated expression of Bcl-2 to induce the apoptosis of tumor cells.
Introduction
Colon cancer as one of the malignant digestive tumor is a major global health problem [1] . Using extensively surgical remove, combined with chemotherapy and radiotherapy after operation is effective in treating colon cancer currently. 5 -fluorouracil, a metabolic type of antitumor drugs, is recognized in clinical to treat colon cancer and other digestive tract cancer [2] . Because of the significant effect on the treatment of colon cancer, 5 -fluorouracil has been applied widely as the first-line drug of colorectal carcinoma chemotherapy. Recent evidence has shown that patients have developed a resistance which potentially has decreased the proportion of people who could be cured [3] . The other main side effects of 5 -fluorouracil are myelosuppression and hemorrhagic enteritis and its low lipophilicity, bad selectivity and evident side effects also limit its application. Juglone (5-hydroxy-1,4-naphthoquinone), a hydroxy naphthoquinone compound, is derived from the fresh root bark, branch bark or green peel of Juglansmandshurica [4] . Many data derived from laboratory studies have suggested that juglone has a good antitumor activity both in vitro or vivo. It has obvious inhibitory effect on the proliferation of Hela cells and esophageal cancer cells in vitro and breast cancer cells, stomach cancer cells and S180 solid cells in mice [5] [6] [7] [8] . However, there is no report a about the effect of juglone on colon cancer in vivo. In this study, the effects and mechanism of juglone alone or combined with 5-fluorouracil on colon cancer CT-26 cells were examined in vivo. In addition, the effects of juglone and juglone combined with 5-fluorouracil on immune function in vivo is discussed.
Materials and methods

Animals, cells, test drugs and chemical reagents
60 male Balb/c mice, which were purchased from Peking University Health Science Center (Beijing, China), were used. CT-26 cells were purchased from Peking Union Medical College (Beijing, China). Juglone was purchased from Sigma. 5-fluorouracil was purchased from Beijing Coal General Hospital (Beijing, China).
All animals were housed in plastic cages (ten mouse per cage). They had free access to water and diets under controlled environmental conditions of humidity (50 ± 10%), lighting (12 h light/dark cycle) and temperature (23 ± 2˚C). CT-26 cells of a suitable concentration were inoculated in culture flasks containing RPMI-1640 solution with 10% of fetal bovine serum. The cultures were then incubated at 37˚C, with 5% CO 2 and saturated humidity; culture transfer was performed once every 2-3 days. The test drugs and chemical reagents were stored in the freezer (4˚C).
Experimental procedure
The study was performed after the mice were allowed to acclimate for 5 days. CT-26 colon cancer mouse models were made on the sixth day by transplanting 0.2mL CT-26 cell suspension (1×10 7 /mL) in the mouse left anterior subcutaneous part. Juglone and 5-fluorouracil were injection via abdominal according to the following group once a day. A total of 60 mice of 5 weeks of age were divided into six groups as follows: group 1, 10 mice for 2% ethanol NS as model group; group 2, 10 mice for 5-fluorouracil (20mg/kg 5-FU) alone as positive drug group; group 3, 10 mice for high-dose juglone (5mg/kg) alone; group 4,10 mice for low-dose juglone (2.5mg/kg) alone; group 5, 10 mice for juglone (5mg/kg) combined with 5-fluorouracil (20mg/kg 5-FU); group 6, 10 mice for juglone (5mg/kg) combined with 5-fluorouracil (10mg/kg 5-FU). After 9 days, complete autopsies were performed on all animals after weighed and took blood by removalling eyeball. At autopsy, the size (length, width and height) of tumors were measured and the maximum size was selected for analysis. Thymus and spleen were examined cautiously. Tumor tissues were fixed in 10% buffered formalin, embedded in paraffin blocks and processed by routine histological methods with hematoxylin and eosin stains, then Calculated the expression rate of nuclear factor Ki-67, E-cadherin (E-cad), B-cell lymphoma 2 gene (Bcl-2). Calculated tumor inhibition rate, thymus and spleen indexes and determined the content of interleukin -2 (IL-2), interferon-γ (IFN-γ), vascular endothelial growth factor (VEGF) by Elisa.
Statistical analysis
Statistical evaluation was done using the SPSS 17.0 and ANOVA. Results presented as mean ± standard deviation (x ത±SD). Table 1 indicates that The inhibition rate of animals given low-dose or high-dose juglone alone and combined with low-dose or high-dose 5-fluorouracil is 31.73%, 40.38%, 56.73% and 75.01% respectively. These data showed that juglone combined with 5-fluorouracil was more cytotoxic than juglone alone and the effect of juglone combined 
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VEGF as the main regulator induces tumor angiogenesis and the protein expression of E-cadherin may suggest a cell adhesion. Compared with the model group, the mouse serum VEGF levels of the groups treated with juglone or juglone combined with 5-fluorouracil is significantly decreased (P<0.05) and similar with the control group which treated with 5-fluorouracil alone. The protein expression of E-cadherin of the groups treated with juglone or juglone combined with 5-fluorouracil is significantly increased (P<0.01) ( Table 2 ). These results suggest that juglone could inhibit proliferation, invasion and metastasis of the tumor in mice. Table 3 shows that expression rate of Bcl-2 of the groups treated with juglone or juglone combined with 5-fluorouracil is significantly decreased (P<0.01). It indicates that juglone could down-regulate the expression of Bcl-2 in CT-26 cells to promote apoptosis. Table 4 shows that thymus index of the groups treated with juglone are significantly increased comparing with the model group and control group (P<0.01). Comparing with the control group, thymus index of the groups treated with juglone combined with 5-fluorouracil are also increased (P<0.01). Juglone and juglone combined with 5-fluorouracil could also increase the spleen index. The mice serum IL-2 and IFN-γ level could be raised after using juglone or juglone combined with 5-fluorouracil. 
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Discussion
In this study, juglone could inhibit the tumor proliferation in mice obviously. Juglone could reduce the risk of proliferation and metastasis of tumor cells by decreasing the level of VEGF in serum and increasing the protein expression of E-cadherin. Furthermore, juglone may improve immune function by increasing some immune factors such as IL-2, INF-γ to improve antitumor activities. The effect of juglone combined with 5-fluorouracil on antitumor is enhanced apparently. And this measure could reduce the side effects of 5-fluorouracil like impaired immune function. The antitumor mechanism of juglone may be involved in blocking Bcl-2 protein expression to induce tumor cells apoptosis. In conclusion, juglone may be a new promising chemotherapeutics for colon cancer. 
